Amdocs Limited (NASDAQ:DOX) has been assigned a consensus rating of “Hold” from the ten brokerages that are currently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and four have given a buy rating to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $72.37.

A number of research analysts have issued reports on DOX shares. Zacks Investment Research lowered shares of Amdocs from a “hold” rating to a “sell” rating in a research report on Monday, August 6th. Citigroup decreased their target price on shares of Amdocs from $79.00 to $77.00 and set a “buy” rating on the stock in a research report on Thursday, August 2nd. BidaskClub lowered shares of Amdocs from a “hold” rating to a “sell” rating in a research report on Friday, July 27th. Barclays set a $73.00 target price on shares of Amdocs and gave the stock a “hold” rating in a research report on Wednesday, August 1st. Finally, Robert W. Baird restated a “hold” rating and set a $72.00 target price on shares of Amdocs in a research report on Thursday, August 2nd.

Amdocs stock traded up $0.10 during trading hours on Wednesday, hitting $63.29. The company had a trading volume of 50,580 shares, compared to its average volume of 688,388. The stock has a market cap of $9.46 billion, a P/E ratio of 17.88, a P/E/G ratio of 2.07 and a beta of 0.52. Amdocs has a one year low of $60.50 and a one year high of $71.72.

Amdocs (NASDAQ:DOX) last released its quarterly earnings results on Tuesday, July 31st. The technology company reported $0.97 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.97. The firm had revenue of $1 billion for the quarter, compared to analysts’ expectations of $1.01 billion. Amdocs had a net margin of 10.56% and a return on equity of 15.00%. As a group, equities analysts forecast that Amdocs will post 3.75 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 19th. Shareholders of record on Friday, September 28th will be given a dividend of $0.25 per share. The ex-dividend date is Thursday, September 27th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.58%. Amdocs’s payout ratio is presently 28.17%.

Several large investors have recently made changes to their positions in DOX. First Hawaiian Bank acquired a new stake in shares of Amdocs during the 3rd quarter worth approximately $825,000. Bank of Montreal Can boosted its position in shares of Amdocs by 6.1% during the 3rd quarter. Bank of Montreal Can now owns 1,025,521 shares of the technology company’s stock worth $67,664,000 after acquiring an additional 59,329 shares in the last quarter. State of Alaska Department of Revenue boosted its position in shares of Amdocs by 2.5% during the 3rd quarter. State of Alaska Department of Revenue now owns 43,396 shares of the technology company’s stock worth $2,863,000 after acquiring an additional 1,064 shares in the last quarter. Royal London Asset Management Ltd. acquired a new stake in shares of Amdocs during the 2nd quarter worth approximately $3,998,000. Finally, Mainstay Capital Management LLC ADV boosted its position in shares of Amdocs by 6,519.0% during the 2nd quarter. Mainstay Capital Management LLC ADV now owns 6,619 shares of the technology company’s stock worth $100,000 after acquiring an additional 6,519 shares in the last quarter. Hedge funds and other institutional investors own 90.91% of the company’s stock.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services solutions to the communications, entertainment, pay TV, and media industry service providers worldwide. The company offers customer experience and monetization solutions that allow its customers to contextual and personalize interactions.

Further Reading: Buyback

Analyst Recommendations for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.